Product Program year 2025 Source: CMS Open Payments

Sovuna

Drug Treatment of uncomplicated malaria

NDC 70954-804-10

Open in the dashboard

General payments

$15,178

905 payments

Research payments

$0

0 payments

Through program year 2025, $15,178 in general payments and $0 in research payments were reported against Sovuna (Treatment of uncomplicated malaria).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $14,342 859
2024 General $835 46

Breakdown

Who paid General payments · program years 2024–2025
  1. ANI Pharmaceuticals, Inc. $15,178 905 payments
Top recipients General payments · program year 2025
  1. Deborah Kim Internal Medicine · Washington, DC $321 2% · 27 payments
  2. Javeria Bhawal Rheumatology · Marietta, GA $311 2% · 20 payments
  3. Jazibeh Qureshi Rheumatology · Catonsville, MD $286 2% · 15 payments
  4. Matthew Farbman Rheumatology · Fort Lauderdale, FL $284 2% · 17 payments
  5. Patrick Farley Physician Assistant · Wheaton, MD $266 2% · 20 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Rheumatology Internal Medicine $9,178 67% · 157 practitioners
  2. Physician Assistant $1,191 9% · 16 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $1,119 8% · 29 practitioners
  4. Internal Medicine $707 5% · 14 practitioners
  5. Physician Assistant, Medical Physician Assistant $300 2% · 9 practitioners

The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Georgia $3,731 26% · 50 recipients
  2. Maryland $2,446 17% · 27 recipients
  3. Florida $2,188 15% · 47 recipients
  4. California $2,105 15% · 40 recipients
  5. New Jersey $1,115 8% · 26 recipients

The top 5 of 17 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

905 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record